Inhibición de MEK para la terapia de células CAR-T: un enfoque para el síndrome de liberación de citoquinas y la

Hui Li1,2, Youming Wang1,2, Yingxiang Wang1

  • 1Department of Hematology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.

PubMed